These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14673208)

  • 1. Cyclin-dependent kinase 5 in amyotrophic lateral sclerosis.
    Nguyen MD; Julien JP
    Neurosignals; 2003; 12(4-5):215-20. PubMed ID: 14673208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase 5 in Lewy body-like inclusions in anterior horn cells of a patient with sporadic amyotrophic lateral sclerosis.
    Nakamura S; Kawamoto Y; Nakano S; Ikemoto A; Akiguchi I; Kimura J
    Neurology; 1997 Jan; 48(1):267-70. PubMed ID: 9008532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cycling at the interface between neurodevelopment and neurodegeneration.
    Nguyen MD; Mushynski WE; Julien JP
    Cell Death Differ; 2002 Dec; 9(12):1294-306. PubMed ID: 12478466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-dependent kinase-5 (CDK5) and amyotrophic lateral sclerosis.
    Bajaj NP
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Dec; 1(5):319-27. PubMed ID: 11464850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions.
    Nguyen MD; Larivière RC; Julien JP
    Neuron; 2001 Apr; 30(1):135-47. PubMed ID: 11343650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A decade of CDK5.
    Dhavan R; Tsai LH
    Nat Rev Mol Cell Biol; 2001 Oct; 2(10):749-59. PubMed ID: 11584302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin-dependent kinase 5 (CDK5) and neuronal cell death.
    Weishaupt JH; Neusch C; Bähr M
    Cell Tissue Res; 2003 Apr; 312(1):1-8. PubMed ID: 12684868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CDK5 and neurodegenerative disease].
    Wang YP; Song JF; Rao ZR
    Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):45-8. PubMed ID: 15127598
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclin-dependent kinase 5 in neurofilament function and regulation.
    Kesavapany S; Li BS; Pant HC
    Neurosignals; 2003; 12(4-5):252-64. PubMed ID: 14673212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdk5 on the brain.
    Smith DS; Greer PL; Tsai LH
    Cell Growth Differ; 2001 Jun; 12(6):277-83. PubMed ID: 11432802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cdk5 behind the wheel: a role in trafficking and transport?
    Smith DS; Tsai LH
    Trends Cell Biol; 2002 Jan; 12(1):28-36. PubMed ID: 11854007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cdk5: mediator of neuronal death and survival.
    Cheung ZH; Ip NY
    Neurosci Lett; 2004 May; 361(1-3):47-51. PubMed ID: 15135890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide.
    Kesavapany S; Li BS; Amin N; Zheng YL; Grant P; Pant HC
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):143-53. PubMed ID: 15023357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of cDK5/p35 by oxidative stress in human neuroblastoma IMR-32 cells.
    Strocchi P; Pession A; Dozza B
    J Cell Biochem; 2003 Mar; 88(4):758-65. PubMed ID: 12577309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death.
    Hamdane M; Bretteville A; Sambo AV; Schindowski K; Bégard S; Delacourte A; Bertrand P; Buée L
    J Cell Sci; 2005 Mar; 118(Pt 6):1291-8. PubMed ID: 15741232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cdk5: multitasking between physiological and pathological conditions.
    Lopes JP; Agostinho P
    Prog Neurobiol; 2011 Jun; 94(1):49-63. PubMed ID: 21473899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective Mechanisms Mediated by CDK5 Inhibition.
    Mushtaq G; Greig NH; Anwar F; Al-Abbasi FA; Zamzami MA; Al-Talhi HA; Kamal MA
    Curr Pharm Des; 2016; 22(5):527-34. PubMed ID: 26601962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
    Patrick GN; Zukerberg L; Nikolic M; de la Monte S; Dikkes P; Tsai LH
    Nature; 1999 Dec; 402(6762):615-22. PubMed ID: 10604467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of CDK5/p25 binding by CDK inhibitors.
    Mapelli M; Massimiliano L; Crovace C; Seeliger MA; Tsai LH; Meijer L; Musacchio A
    J Med Chem; 2005 Feb; 48(3):671-9. PubMed ID: 15689152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.